Literature DB >> 27756514

Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised.

Kim T Mueser1, Min Kim2, Jean Addington3, Susan R McGurk4, Sarah I Pratt5, Donald E Addington3.   

Abstract

The Quality of Life Scale (QLS) is a frequently used semistructured interview for the assessment of functional outcomes in schizophrenia. Despite the use of the QLS for over 30years, the original 4-factor structure of the instrument (Interpersonal Relations, Instrumental Role, Intrapsychic Foundations, and Common Objects and Activities) has not been rigorously examined. Exploratory factor analyses (EFAs) and confirmatory factor analyses (CFAs) were used to evaluate the factor structure of the QLS in two independent datasets, including a mixed diagnostic sample of multi-episode participants (N=247), and a sample of individuals with a first episode of psychosis (N=337). A CFA with the first dataset indicated a poor fit for the 4-factor model of the QLS. Subsequent EFAs on this dataset led to a more promising 3-factor solution including 16/21 of the QLS items, which were similar to the first 3 of 4 factors originally proposed for the QLS. CFAs on the same dataset indicated that the 3-factor model for the QLS-Revised (QLS-R) fit the data well. This factor structure was evaluated with the second dataset using CFA and was also found to be fit the data well. The results support the robustness of the 3-factor model of the QLS-R in schizophrenia and mixed diagnostic samples. Future research should evaluate the validity of the 3-factor model of the QLS-R, and consider the merits of changing the name of the Intrapsychic Foundations factor to Motivation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Confirmatory factor analysis; Exploratory factor analysis; Psychosocial functioning; Quality of life scale; Recovery; Structural equation modeling

Mesh:

Year:  2016        PMID: 27756514      PMCID: PMC5365361          DOI: 10.1016/j.schres.2016.10.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  27 in total

1.  The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale.

Authors:  R M Norman; A K Malla; T McLean; L P Voruganti; L Cortese; E McIntosh; S Cheng; A Rickwood
Journal:  Acta Psychiatr Scand       Date:  2000-10       Impact factor: 6.392

2.  Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.

Authors:  Diana Perkins; Jeffrey Lieberman; Hongbin Gu; Mauricio Tohen; Joseph McEvoy; Alan Green; Robert Zipursky; Stephen Strakowski; Tonmoy Sharma; René Kahn; Raquel Gur; Gary Tollefson
Journal:  Br J Psychiatry       Date:  2004-07       Impact factor: 9.319

3.  Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.

Authors:  Jonathan Rabinowitz; Stephen Z Levine; George Garibaldi; Dragana Bugarski-Kirola; Carmen Galani Berardo; Shitij Kapur
Journal:  Schizophr Res       Date:  2012-02-06       Impact factor: 4.939

4.  Multiple-family group treatment for English- and Vietnamese-speaking families living with schizophrenia.

Authors:  Gail M Bradley; Grace M Couchman; Amaryll Perlesz; Anh Thu Nguyen; Bruce Singh; Colin Riess
Journal:  Psychiatr Serv       Date:  2006-04       Impact factor: 3.084

5.  Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden.

Authors:  K T Mueser; A Sengupta; N R Schooler; A S Bellack; H Xie; I D Glick; S J Keith
Journal:  J Consult Clin Psychol       Date:  2001-02

6.  Study protocol: The development of a pilot study employing a randomised controlled design to investigate the feasibility and effects of a peer support program following discharge from a specialist first-episode psychosis treatment centre.

Authors:  Jo Robinson; Annie Bruxner; Susy Harrigan; Sarah Bendall; Eoin Killackey; Vittoria Tonin; Katherine Monson; Melissa Thurley; Shona Francey; Alison R Yung
Journal:  BMC Psychiatry       Date:  2010-05-25       Impact factor: 3.630

7.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

8.  Psychometric properties of the recovery measurement in homeless people with severe mental illness.

Authors:  Vincent Girard; Aurelie Tinland; El Had Mohamed; Laurent Boyer; Pascal Auquier
Journal:  Schizophr Res       Date:  2015-10-28       Impact factor: 4.939

9.  Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Joseph P McEvoy; Jeffrey A Lieberman; Diana O Perkins; Robert M Hamer; Hongbin Gu; Arthur Lazarus; Dennis Sweitzer; Christina Olexy; Peter Weiden; Stephen D Strakowski
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

10.  Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Diego Novick; Josep Maria Haro; Jaume Aguado; Zhanglin Cui
Journal:  Qual Life Res       Date:  2012-12-14       Impact factor: 4.147

View more
  5 in total

1.  Metacognition Is Necessary for the Emergence of Motivation in People With Schizophrenia Spectrum Disorders: A Necessary Condition Analysis.

Authors:  Lauren Luther; Kelsey A Bonfils; Ruth L Firmin; Kelly D Buck; Jimmy Choi; Giancarlo Dimaggio; Raffaele Popolo; Kyle S Minor; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2017-12       Impact factor: 2.254

2.  Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia.

Authors:  Daniel Fulford; Danijela Piskulic; Jean Addington; John M Kane; Nina R Schooler; Kim T Mueser
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

3.  Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.

Authors:  Ebrahim Haroon; James R Welle; Bobbi J Woolwine; David R Goldsmith; Wendy Baer; Trusharth Patel; Jennifer C Felger; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2020-01-15       Impact factor: 7.853

4.  Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation.

Authors:  Russell K Schutt; Haiyi Xie; Kim T Mueser; Matthew A Killam; Jonathan Delman; Shaun M Eack; Raquelle Mesholam-Gately; Sarah I Pratt; Luis Sandoval; Meghan M Santos; Laura R Golden; Matcheri S Keshavan
Journal:  BMC Psychiatry       Date:  2022-09-01       Impact factor: 4.144

5.  Uncontrolled trial of specialized, multi-component care for individuals with first-episode psychosis: Effects on motivation orientations.

Authors:  Nicholas J K Breitborde; Jacob G Pine; Aubrey M Moe
Journal:  Early Interv Psychiatry       Date:  2019-12-30       Impact factor: 2.721

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.